Q4?

Kagge
NANO 26.02.2020 kl 16:58 1063

Når kom det noe positivt på en Q-presentasjon sist??

Jeg er inne og håper selvsagt på noe nå.. Men håp er håp, og det er vel pessimisten i meg som føler at Q-pres somregel blir skuffelse, mye er nok sikkert fordi forventningene er for høye?

Jeg tror forventningene er like vanskelige å innfri i år..??
Redigert 21.01.2021 kl 00:44 Du må logge inn for å svare
Slettet bruker
26.02.2020 kl 17:02 1035

Bravo har forlatt skuta.


Nordic Nanovector Appoints Dr Lars Nieba as interim Chief Executive Officer
2020-02-26 16:57 GMT+01

Nordic Nanovector ASA (OSE: NANO) announces that Dr Lars Nieba has been appointed interim Chief Executive Officer with immediate effect. Dr Nieba, who is currently the Company's Chief Technology Officer, replaces Eduardo Bravo who as of today has left Nordic Nanovector to pursue other career opportunities.

Dr Nieba joined Nordic Nanovector on 1 December 2019 from Bayer AG where he served in various operational and strategic roles, Dr Nieba was most recently responsible for driving Bayer's Chemistry, Manufacturing and Controls (CMC) strategy for biologicals. He joined Bayer in 2016 following 13 years at F. Hoffmann-La Roche Ltd., where he held various leadership roles in clinical, operations, supply planning, biologics technology and technical business development. Prior Dr Nieba worked for Cytos Biotechnology where he served as Head of Therapeutic Vaccine Research.

Dr Nieba gained a PhD from the Max-Planck-Institute for Biochemistry, München and Institute for Biochemistry at the University of Zürich, and an Executive MBA from the University of St. Gallen, Switzerland.

Jan H. Egberts, MD, Chairman of Nordic Nanovector, commented: "The Board is very pleased to appoint Lars Nieba as Nordic Nanovector's interim CEO. We believe that his significant operational, development and product supply expertise will be crucial as we work towards completing the PARADIGME study and prepare for the planned filing for Betalutin® with the FDA. On behalf of the Board I would like to thank Eduardo for his contribution as CEO."

For further information, please contact:

IR enquiries

Jan H. Egberts, Chairman of Nordic Nanovector
Redigert 21.01.2021 kl 00:44 Du må logge inn for å svare
mofi1
26.02.2020 kl 17:03 1027

Hvordan skal vi tolke det?
Redigert 21.01.2021 kl 00:44 Du må logge inn for å svare
Coiltubing
26.02.2020 kl 17:09 986

NANO er vel oppkjøpt av Big Pharma, og Lars Nieba sitter foreløpig til kabalen er lagt! :-)
Redigert 21.01.2021 kl 00:44 Du må logge inn for å svare
Slettet bruker
26.02.2020 kl 17:13 959

Det tror jeg nærmest man kan utelukke.
Ingen grunn for CEO å dra på dagen da på denne måten, her må det ligge mer, dessverre negativt bak.
Redigert 21.01.2021 kl 00:44 Du må logge inn for å svare
Bullinvestor
26.02.2020 kl 17:17 925

Er ikke bekymret, er vel som i fotball med overgangsvinduet. Ingen trenger å tape på dette!!!
Redigert 21.01.2021 kl 00:44 Du må logge inn for å svare